Arca Biopharma sell StockNews.com
Start price
30.12.23
/
50%
€1.54
Target price
30.12.24
-
Performance (%)
229.06%
End price
31.12.24
-
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com for Arca Biopharma is trending in the completely wrong direction and now has a performance of 229.06%. A total of €2.85 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arca Biopharma | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten